Filing Flows

Filing Flows › SkinHealth Systems (SKIN) › Q3 2026 › vs Q2 2026

SkinHealth Systems (SKIN) Q3 2026 vs Q2 2026 (quarter over quarter)

SkinHealth Systems's revenue fell $2.9M (-4%) from $72.1M in Q2 2026 to $69.2M in Q3 2026. The biggest changes: Consumables −$3.4M (-6%); Delivery Systems +$506K (+3%).

SkinHealth Systems, Q3 2026: revenue $69.2M (-2% year over year), operating margin 7.2%, net loss $888K, operating cash flow $11.3M. The chart draws each line against Q2 2026, the increases inside each band.

SkinHealth Systems: what changed, Q3 2026 vs Q2 2026SkinHealth Systems: what changed, Q3 2026 vs Q2 2026Free cash flow (OCF − capex)$8.9MOperating cash flow$8.6MWorking capital & other$8.3MOperating cash sources$6.8MCosts & expenses−$4.7MOperating costs−$4.3MConsumables−$3.4MGeneral & admin−$2.8MNet loss−$1.8MNet loss absorbed−$1.8M

Margins

Q3 2026Q2 2026Change
Free cash flow margin16.1%3.1%+13.0 pts

Every line

LineQ3 2026Q2 2026Change%
Consumables$50.4M$53.9M−$3.4M-6%
Delivery Systems$18.8M$18.3M$506K+3%
Revenue$69.2M$72.1M−$2.9M-4%
Net loss$888K$2.7M−$1.8M-67%
Costs & expenses$70.1M$74.8M−$4.7M-6%
Operating costs$64.2M$68.5M−$4.3M-6%
Interest & other, net$5.1M$5.0M$53K+1%
Income tax$780K$1.2M−$428K-35%
Cost of revenue$22.0M$22.8M−$751K-3%
Research & development$1.7M$1.4M$255K+18%
Sales & marketing$20.0M$21.0M−$1.0M-5%
General & admin$20.5M$23.3M−$2.8M-12%
Operating cash sources$12.2M$5.3M$6.8M+128%
Depreciation & amortization$4.0M$4.0M−$15K-0.4%
Share-based compensation$1.4M$2.9M−$1.5M-50%
Working capital & other$6.7M−$1.6M$8.3M—
Net loss absorbed$888K$2.7M−$1.8M-67%
Operating cash flow$11.3M$2.7M$8.6M+322%
Free cash flow (OCF − capex)$11.2M$2.2M$8.9M+398%
Capital expenditures$93K$427K−$334K-78%

Questions

How much did SkinHealth Systems's revenue grow quarter over quarter in Q3 2026?

SkinHealth Systems's revenue fell $2.9M (-4%) from $72.1M in Q2 2026 to $69.2M in Q3 2026.

What drove SkinHealth Systems's revenue change in Q3 2026?

Consumables −$3.4M (-6%); Delivery Systems +$506K (+3%).

Q3 2026 results → · Compare in the interactive Sankey →